Quick Answer
Replimune Group, Inc. reported Research And Development Expense of $189.45 million for the year ending 2025.
- Replimune Group, Inc. showed an increase of +8.3% in Research And Development Expense from 2024 to 2025.
- This data is from Replimune Group, Inc.'s annual report (Form 10-K), filed with the SEC on May 22, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Replimune Group, Inc.'s Research And Development Expense has grown by 2,631.4%.
- Historical annual values: Fiscal year 2025: $189.45 million | Fiscal year 2024: $174.96 million | Fiscal year 2023: $126.53 million | Fiscal year 2022: $79.55 million | Fiscal year 2021: $56.75 million | Fiscal year 2020: $38.76 million | Fiscal year 2019: $22.17 million | Fiscal year 2018: $13.52 million | Fiscal year 2017: $6.94 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: